BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Now in its twelfth year, BioPharm America creates a robust exchange among hundreds of executives from venture capital firms, major pharmaceutical companies, academic institutions and biotechnology companies of every size and stage, from mature to startup. The event brings dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development.
A primary focus of BioPharm America™ is the one-to-one meetings driven by partneringONE®, the industry's most robust software platform. Delegates can request and schedule meetings tailored to their strategic business goals to create a dynamic personalized agenda that includes regular alerts for further meeting opportunities.
The impetus behind this intensive business development activity is a two-day conference program that features thought leaders and executives from across the life science industry. To help bring attention to early stage projects and small entrepreneurial companies, BioPharm America features special tracks specifically designed for startups and young companies to get on the radar of the global life science community and to make the connections that matter. Leading pharmaceutical companies attend BioPharm America in search of innovation.
Engaging panel discussions cover topics of interest to dealmakers including licensing, investment and business development. Held in Boston each September, the event attracts 800+ delegates from over 500 companies who participate in 2,300+ scheduled one-to-one meetings.
In addition, BioPharm America is now part of Biotech Week Boston, providing concurrent events and highlights which attract a total of over 4,500 life science leaders, scientists and innovators.
General Registration: USD 1095.0
Biotech Startup: USD 595.0
Investor: USD 0.0